News

Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

Nemysis is pleased to announce the further strengthening of its IP portfolio in relation to its unique and innovative nanoparticulate…

2 years ago

Spago Nanomedical Receives Declarations of Intent from the Largest Owner, Board and Management Team Regarding the Exercise of TO12

LUND, SWEDEN / ACCESSWIRE / May 23, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) ("Spago Nanomedical" or the…

2 years ago

Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…

2 years ago

Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29

BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company…

2 years ago

Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB

GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Today, on Wednesday May 22, 2024, IRLAB Therapeutics…

2 years ago

Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries

The Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo™…

2 years ago

HealthJoy Celebrates 10 Years of Bringing Benefits to Life

Care navigation platform celebrates a decade of amplifying benefit strategies to help employers contain costs and improve health outcomesCHICAGO, IL…

2 years ago

Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation

Updates on ETC Marketing, Inc and Ownership of ITV-1 and IPFALLEN, TX / ACCESSWIRE / May 22, 2024 / Enzolytics,…

2 years ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

Using their SPID®-Technology, Laxxon Medical has manufactured a 3D printed oral tablet combining a GLP-1 receptor agonist and a permeation…

2 years ago

GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations

FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any…

2 years ago